Dale Hershman recently joined Matthew Tuttle on the Financial H.E.A.T. Podcast for a wide-ranging conversation on investing, psychology, biotech stocks, and passive income strategies.
In the featured clips below, Dale discusses why dividend investing is often misunderstood, the growing investment impact of GLP-1 companies like Eli Lilly, and how he evaluates biotech stocks and healthcare innovation opportunities.
Watch the full episode of the Financial H.E.A.T. Podcast here: https://www.youtube.com/watch?v=peHq6PKOpto
